Xenetic Biosciences(XBIO) - 2021 Q1 - Quarterly Report
Xenetic Biosciences(XBIO)2021-05-11 21:00☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q 45-2952962 (IRS Employer Identification No.) 40 Speen Street, Suite 102 Framingham, Massachusetts 01701 (Address of principal executive offices and zip code) ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 781-778-7720 For the transition period from to Commission File Number: 001- ...